Shuiping Capital

Public records describe the firm's strategy as spanning growth equity, PIPE (private investment in public equity), and general venture investing. This combination suggests the firm can participate in late-stage private funding rounds as well as structured investments in publicly listed Chinese companies. Specific sector preferences or stage allocations have not been publicly disclosed by the firm.

PIPE transactions involve negotiated investments in publicly traded companies, typically at a discount to prevailing market prices. For a China-based private equity firm, this requires regulatory permissions and settlement infrastructure beyond what standard venture capital firms need. Shuiping Capital's inclusion of PIPE in its mandate indicates the firm maintains or accesses the licenses and market relationships necessary to execute these cross-market transactions.

The founding principals and current investment decision-makers at Shuiping Capital have not been identified in public records. The firm does not maintain a publicly accessible website, and no principals have been named in available regulatory filings or media coverage. This opacity is not unusual among smaller private equity managers in Beijing that operate without institutional limited partners or international fundraising mandates.

No. Shuiping Capital does not publish AUM figures, and no credible third-party estimate exists in the public domain. The firm does not appear to have registered with or reported to international limited partner databases, making any AUM assertion speculative.

The structural difference lies in the PIPE capability. Most venture capital firms in China focus exclusively on unlisted companies and exit through IPO or trade sale. Shuiping Capital's mandate includes investing directly in listed companies — a crossover approach that blurs the line between private equity and public-markets investing and requires operational infrastructure that pure VC firms typically do not build.